Exactech announced that the first shoulder surgeries in the U.S. and Europe have reported excellent experiences with Equinoxe® with VERASENSE™, the industry’s only intraoperative wireless shoulder sensor.
VERASENSE’s sensor technologies transmit data wirelessly to an intraoperative monitor that allows surgeons to make informed decisions on load magnitude and center of load location in real time.
“Exactech’s growing portfolio of innovative technologies, such as VERASENSE and ExactechGPS, allow us to provide surgeons with the tools they need to help patients get back to what they love faster,” said Vice President of Extremities Chris Roche. “We are very proud of our partnership with OrthoSensor and look forward to even more surgeries around the world with this unique technology.”
Increased availability of VERASENSE is expected in the first half of 2021.
Exactech announced that the first shoulder surgeries in the U.S. and Europe have reported excellent experiences with Equinoxe® with VERASENSE™, the industry’s only intraoperative wireless shoulder sensor.
VERASENSE’s sensor technologies transmit data wirelessly to an intraoperative monitor that allows surgeons to make informed decisions...
Exactech announced that the first shoulder surgeries in the U.S. and Europe have reported excellent experiences with Equinoxe® with VERASENSE™, the industry’s only intraoperative wireless shoulder sensor.
VERASENSE’s sensor technologies transmit data wirelessly to an intraoperative monitor that allows surgeons to make informed decisions on load magnitude and center of load location in real time.
“Exactech’s growing portfolio of innovative technologies, such as VERASENSE and ExactechGPS, allow us to provide surgeons with the tools they need to help patients get back to what they love faster,” said Vice President of Extremities Chris Roche. “We are very proud of our partnership with OrthoSensor and look forward to even more surgeries around the world with this unique technology.”
Increased availability of VERASENSE is expected in the first half of 2021.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
